Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The link between pharmacodynamics and physiologically based pharmacokinetic models.

Perera V, Elmeliegy MA, Rao G, Forrest A.

Clin Pharmacol Ther. 2013 Feb;93(2):151-2. doi: 10.1038/clpt.2012.178. Epub 2013 Jan 9. No abstract available.

PMID:
23299648
2.

Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model.

Elmeliegy MA, Carcaboso AM, L Chow LM, Zhang ZM, Calabrese C, Throm SL, Wang F, Baker SJ, Stewart CF.

J Pharm Sci. 2011 Oct;100(10):4210-4. doi: 10.1002/jps.22723. Epub 2011 Aug 11.

3.

Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation.

Elmeliegy MA, Carcaboso AM, Tagen M, Bai F, Stewart CF.

Clin Cancer Res. 2011 Jan 1;17(1):89-99. doi: 10.1158/1078-0432.CCR-10-1934. Epub 2010 Nov 18.

4.

Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.

Carcaboso AM, Elmeliegy MA, Shen J, Juel SJ, Zhang ZM, Calabrese C, Tracey L, Waters CM, Stewart CF.

Cancer Res. 2010 Jun 1;70(11):4499-508. doi: 10.1158/0008-5472.CAN-09-4264. Epub 2010 May 11.

5.

Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.

Shen J, Carcaboso AM, Hubbard KE, Tagen M, Wynn HG, Panetta JC, Waters CM, Elmeliegy MA, Stewart CF.

Cancer Res. 2009 Jul 15;69(14):5885-92. doi: 10.1158/0008-5472.CAN-09-0700. Epub 2009 Jun 30.

Supplemental Content

Loading ...
Support Center